| 000 | 00989 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512170626.0 | ||
| 264 | 0 | _c19680509 | |
| 008 | 196805s 0 0 eng d | ||
| 022 | _a0001-6314 | ||
| 024 | 7 |
_a10.1111/j.1600-0404.1967.tb02091.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOftedal, S I | |
| 245 | 0 | 0 |
_aChloroquine neuromyopathy. _h[electronic resource] |
| 260 |
_bActa neurologica Scandinavica _c1967 |
||
| 300 |
_a147-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChloroquine _xadverse effects |
| 650 | 0 | 4 | _aElectromyography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJoint Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aMuscles _xpathology |
| 650 | 0 | 4 |
_aParesis _xchemically induced |
| 700 | 1 | _aMunthe-Kaas, A W | |
| 773 | 0 |
_tActa neurologica Scandinavica _gvol. 43 _gno. S31 _gp. 147-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0404.1967.tb02091.x _zAvailable from publisher's website |
| 999 |
_c5584163 _d5584163 |
||